Teva-Triamterene/HCTZ (2020-07-24)
- Starting date:
- July 24, 2020
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-73637
Last updated:
2020-07-31
Summary
-
Product:
Teva-Triamterene/HCTZ
Reason
The assay for Triamterene is out of specification in the affected lot and the assay for Hydrochlorothiazide (HCTZ) is out of trend in the affected lot.
Alternate Brand Names: Maxzide, Dyazide, Dyrenium
Depth of distribution
Wholesalers, Retailers
Affected products
Teva-Triamterene/HCTZ
DIN, NPN, DIN-HIM
DIN 00532657
Dosage form
Tablet
Strength
Triamterene 50mg and Hydrochlorothiazide 25mg
Lot or serial number
35360453A
Companies
- Recalling Firm
-
Teva Canada Limited
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Teva Canada Limited
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA